 BRIDGEWATER, N.J., Sept. 02, 2021 GLOBE NEWSWIRE -- Osmotica Pharmaceuticals plc Nasdaq: OSMT Osmotica or the Company, a fully integrated biopharmaceutical company, announced today that Brian Markison, Chief Executive Officer, and James JD Schaub, Chief Operating Officer, will present at the H.C. Wainwright 23rd Annual Global Investment Conference as follows: 